全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Jaroslav Racek , Petr Pazdiora
来源:[J].Kidney & Blood Pressure Research(IF 1.596), 2016, Vol.41 (2), pp.139-147DOAJ
摘要:Background/Aims: The immune response to influenza vaccine may be influenced by many factors, e.g. age, comorbidities or inflammation, and iron status. Methods: We studied the vaccine-induced production of hemagglutination-inhibition antibodies (HI) in 133 hemodialysis patients (H...
作者:Jaroslav Racek , Ladislav Trefil ...
来源:[J].Nutrients(IF 2.072), 2016, Vol.8 (1)DOAJ
摘要:Moderate regular consumption of alcoholic beverages is believed to protect against atherosclerosis but can also increase homocysteine or dimethylglycine, which are putative risk factors for atherosclerosis. We aimed (1) to investigate the effect of alcohol consumption on vitamins...
作者:Jaroslav Racek , Michal Vostrý ...
来源:[J].Kidney & Blood Pressure Research(IF 1.596), 2014, Vol.39 (1), pp.50-57DOAJ
摘要:Background/Aims: Asymmetric dimethylarginine (ADMA) is a prognostic factor in patients with chronic kidney disease (CKD). However, the relationships among factors influencing the metabolism of ADMA and the CKD progression are not fully understood. Methods: Serum ADMA, and va...
作者:Jaroslav Racek , Renata Havrankova ...
来源:[J].Journal of Applied Biomedicine(IF 0.978), 2008, Vol.6 (4), pp.195DOAJ
摘要:The target of the present work was a study of the oxidation-reduction system of the organism damagedwith ionizing radiation. The parameters chosen for examination were: the superoxide dismutaseactivity in erythrocytes, the concentration of reduced glutathione in erythrocytes, the...
作者:Jaroslav Racek , Daniel Rajdl ...
来源:[J].Wiener klinische Wochenschrift(IF 0.813), 2013, Vol.125 (15-16), pp.448-452Springer
摘要:Summary(#br) Background(#br)Hepcidin is a key regulator of iron metabolism. It binds to ferroportin and causes the trapping of iron in cells, rendering it unavailable for erythropoiesis. The synthesis of hepcidin is upregulated by high iron stores and inflammation. Haemodialysed ...
作者:Jaroslav Racek , Ludek Müller
来源:[J].Biological Trace Element Research(IF 1.307), 2018, Vol.183 (2), pp.192-199Springer
摘要:Abstract(#br)Chromium (Cr) is considered as an important mineral, involved in biochemical reactions in human metabolic pathways. Organically bound Cr supplementation has been suggested to improve glycemia especially in patients with type 2 diabetes mellitus, but there are co...
作者:Jaroslav Racek , Ivo Valkovský
来源:[J].Journal of Renal Nutrition(IF 1.75), 2015, Vol.25 (2), pp.247-249Elsevier
摘要:Levels of the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA) are elevated and endothelial progenitor cells (EPCs) decreased in patients undergoing renal transplantation (Tx) and may contribute to cardiovascular complications. In this study, w...
作者:Jaroslav Racek , Marek Minarik ...
来源:[J].Tumor Biology(IF 2.518), 2015, Vol.36 (12), pp.9215-9222Springer
摘要:Abstract(#br)Erlotinib is a low molecular weight tyrosine kinase inhibitor (TKI) directed at epidermal growth factor receptor (EGFR), widely used in the treatment of locally advanced or metastatic-stage non-small cell lung cancer (NSCLC). Although introduction of EGFR-TKIs h...
作者:Jaroslav Racek , Olga Mareckova ...
来源:[J].Wiener klinische Wochenschrift(IF 0.813), 2008, Vol.120 (15-16), pp.478-485Springer
摘要:Summary(#br)BACKGROUND: Levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) are elevated in chronic kidney disease (CKD) and may contribute to vascular complications. In this study we tested the hypothesis that elevated ADMA can be red...
作者:Jaroslav Racek , Ivana Vyhnankova ...
来源:[J].Wiener klinische Wochenschrift(IF 0.813), 2010, Vol.122 (15-16), pp.466-473Springer
摘要:Summary(#br)BACKGROUND: Obesity is a known high-risk factor for the development of vascular diseases and chronic kidney disease (CKD). In this study we aimed to elucidate the impact of adipose tissue on the inflammatory state in CDK patients with obesity. PATIENTS AND METHOD...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×